109 related articles for article (PubMed ID: 17717129)
1. Genomic profiling of circulating plasma RNA for the analysis of cancer.
Collado M; Garcia V; Garcia JM; Alonso I; Lombardia L; Diaz-Uriarte R; Fernández LA; Zaballos A; Bonilla F; Serrano M
Clin Chem; 2007 Oct; 53(10):1860-3. PubMed ID: 17717129
[TBL] [Abstract][Full Text] [Related]
2. Sensitive assays for detection of lung cancer. Molecular markers in blood samples.
Fournier MV; Martin KJ; Graner E; Pardee AB
Methods Mol Med; 2003; 75():239-50. PubMed ID: 12407744
[No Abstract] [Full Text] [Related]
3. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
4. Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.
Lauriola M; Ugolini G; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Rivetti S; Mattei G; Coppola D; Strippoli P; Taffurelli M; Solmi R
Int J Oncol; 2010 Aug; 37(2):519-25. PubMed ID: 20596680
[TBL] [Abstract][Full Text] [Related]
5. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer.
Han M; Liew CT; Zhang HW; Chao S; Zheng R; Yip KT; Song ZY; Li HM; Geng XP; Zhu LX; Lin JJ; Marshall KW; Liew CC
Clin Cancer Res; 2008 Jan; 14(2):455-60. PubMed ID: 18203981
[TBL] [Abstract][Full Text] [Related]
6. Detection of cytokeratin-20-positive cells in preoperative and postoperative blood samples from colorectal cancer patients by real-time RT-PCR.
Šamija I; Lukač J; Mubrin MK; Kirac I; Kovačević D; Kusić Z
Int J Biol Markers; 2013 Jun; 28(2):174-81. PubMed ID: 23558939
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
Moshayoff V; Faktor O; Laghi L; Celesti G; Peretz T; Keret D; Cohen D; Israeli E
PLoS One; 2016; 11(7):e0159522. PubMed ID: 27441409
[TBL] [Abstract][Full Text] [Related]
8. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Guo Y; Fu P; Zhu H; Reed E; Remick SC; Petros W; Mueller MD; Yu JJ
Oncol Rep; 2012 Jan; 27(1):286-92. PubMed ID: 21971700
[TBL] [Abstract][Full Text] [Related]
9. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
10. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers.
Mengual L; Ars E; Lozano JJ; Burset M; Izquierdo L; Ingelmo-Torres M; Gaya JM; Algaba F; Villavicencio H; Ribal MJ; Alcaraz A
Actas Urol Esp; 2014 Apr; 38(3):143-9. PubMed ID: 24206626
[TBL] [Abstract][Full Text] [Related]
15. A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer.
Chien CC; Chang CC; Yang SH; Chen SH; Huang CJ
Oncol Rep; 2006 Apr; 15(4):919-26. PubMed ID: 16525680
[TBL] [Abstract][Full Text] [Related]
16. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
17. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
[TBL] [Abstract][Full Text] [Related]
18. [Circulating MicroRNAs as Biomarkers of Colorectal Cancer].
Umemura T; Kuroki C
Rinsho Byori; 2015 Mar; 63(3):336-46. PubMed ID: 26524857
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.
Solmi R; Ugolini G; Rosati G; Zanotti S; Lauriola M; Montroni I; del Governatore M; Caira A; Taffurelli M; Santini D; Coppola D; Guidotti L; Carinci P; Strippoli P
BMC Cancer; 2006 Oct; 6():250. PubMed ID: 17054783
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
